|
1
|
Dietschy JM: Dietary fatty acids and the
regulation of plasma low density lipoprotein cholesterol
concentrations. J Nutr. 128:444S–448S. 1998.PubMed/NCBI
|
|
2
|
Videla LA, Rodrigo R, Araya J and
Poniachik J: Insulin resistance and oxidative stress
interdependency in non-alcoholic fatty liver disease. Trends Mol
Med. 12:555–558. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aronis A, Madar Z and Tirosh O: Mechanism
underlying oxidative stress-mediated lipotoxicity: exposure of
J774.2 macrophages to triacylglycerols facilitates mitochondrial
reactive oxygen species production and cellular necrosis. Free
Radic Biol Med. 38:1221–1230. 2005. View Article : Google Scholar
|
|
4
|
McGarry JD: Banting lecture 2001:
dysregulation of fatty acid metabolism in the etiology of type 2
diabetes. Diabetes. 51:7–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Li R, Li Y, Chen W, Zhao S and
Chen G: Vitamin A status affects obesity development and hepatic
expression of key genes for fuel metabolism in Zucker fatty rats.
Biochem Cell Biol. 90:548–557. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chawla A, Repa JJ, Evans RM and
Mangelsdorf DJ: Nuclear receptors and lipid physiology: opening the
X-files. Science. 294:1866–1870. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clarke SD: The multi-dimensional
regulation of gene expression by fatty acids: polyunsaturated fats
as nutrient sensors. Curr Opin Lipidol. 15:13–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jump DB, Botolin D, Wang Y, Xu J,
Christian B and Demeure O: Fatty acid regulation of hepatic gene
transcription. J Nutr. 135:2503–2506. 2005.PubMed/NCBI
|
|
9
|
Jump DB: N-3 polyunsaturated fatty acid
regulation of hepatic gene transcription. Curr Opin Lipidol.
19:242–247. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boelsterli UA and Bedoucha M:
Toxicological consequences of altered peroxisome
proliferator-activated receptor gamma (PPARgamma) expression in the
liver: insights from models of obesity and type 2 diabetes. Biochem
Pharmacol. 63:1–10. 2002. View Article : Google Scholar
|
|
11
|
Schultz JR, Tu H, Luk A, et al: Role of
LXRs in control of lipogenesis. Genes Dev. 14:2831–2838. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Repa JJ, Turley SD, Lobaccaro JA, et al:
Regulation of absorption and ABC1-mediated efflux of cholesterol by
RXR heterodimers. Science. 289:1524–1529. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jong MC, Voshol PJ, Muurling M, et al:
Protection from obesity and insulin resistance in mice
overexpressing human apolipoprotein C1. Diabetes. 50:2779–2785.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galetto R, Albajar M, Polanco JI, Zakin MM
and Rodriguez-Rey JC: Identification of a
peroxisome-proliferator-activated-receptor response element in the
apolipoprotein E gene control region. Biochem J. 357:521–527. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clarke SD and Jump DB: Dietary
polyunsaturated fatty acid regulation of gene transcription. Annual
review of nutr. 14:83–98. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jump DB, Thelen A and Mater M: Dietary
polyunsaturated fatty acids and hepatic gene expression. Lipids.
34:S209–S212. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sampath H and Ntambi JM: Regulation of
gene expression by polyunsaturated fatty acids. Heart Metab.
32:32–35. 2006.
|
|
18
|
Pan XF, Wen CX and Xu JH: Comparison of
two cell lines for cell model of hepatocytic steatosis in vitro.
Journal of Guangdong Pharmaceutical College. 1:0422010.
|
|
19
|
Yang X, Zhang Y, Lin J, et al: A lower
proportion of dietary saturated/monounsaturated/polyunsaturated
fatty acids reduces the expression of adiponectin in rats fed a
high-fat diet. Nutr Res. 32:285–291. 2012. View Article : Google Scholar
|
|
20
|
Di Nunzio M, Valli V and Bordoni A: Pro-
and anti-oxidant effects of polyunsaturated fatty acid
supplementation in HepG2 cells. Prostaglandins, Leukot Essent Fatty
Acids. 85:121–127. 2011.PubMed/NCBI
|
|
21
|
Ricchi M, Odoardi MR, Carulli L, et al:
Differential effect of oleic and palmitic acid on lipid
accumulation and apoptosis in cultured hepatocytes. J Gastroenterol
Hepatol. 24:830–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wong SH, Fisher EA and Marsh JB: Effects
of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA
and secretion of very low density lipoprotein in HepG2 cells.
Arteriosclerosis. 9:836–841. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vidal-Puig A, Jimenez-Liñan M, Lowell BB,
et al: Regulation of PPAR gamma gene expression by nutrition and
obesity in rodents. J Clin Invest. 97:2553–2561. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Knight BL, Hebbachi A, Hauton D, et al: A
role for PPARalpha in the control of SREBP activity and lipid
synthesis in the liver. Biochem J. 389:413–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Patel DD, Knight BL, Wiggins D, Humphreys
SM and Gibbons GF: Disturbances in the normal regulation of
SREBP-sensitive genes in PPAR alpha-deficient mice. J Lipid Res.
42:328–337. 2001.PubMed/NCBI
|
|
26
|
Bensinger SJ and Tontonoz P: Integration
of metabolism and inflammation by lipid-activated nuclear
receptors. Nature. 454:470–477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wójcicka G, Jamroz-Wiśniewska A,
Horoszewicz K and Bełtowski J: Liver X receptors (LXRs). Part I:
structure, function, regulation of activity, and role in lipid
metabolism. Postepy Hig Med Dosw (Online). 61:736–759.
2007.PubMed/NCBI
|
|
28
|
Laffitte BA, Joseph SB, Walczak R, et al:
Autoregulation of the human liver X receptor alpha promoter. Mol
Cell Biol. 21:7558–7568. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tobin KA, Steineger HH, Alberti S, et al:
Cross-talk between fatty acid and cholesterol metabolism mediated
by liver X receptor-alpha. Mol Endocrinol. 14:741–752.
2000.PubMed/NCBI
|
|
30
|
Horton JD, Goldstein JL and Brown MS:
SREBPs: activators of the complete program of cholesterol and fatty
acid synthesis in the liver. J Clin Invest. 109:1125–1131. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu J, Nakamura MT, Cho HP and Clarke SD:
Sterol regulatory element binding protein-1 expression is
suppressed by dietary polyunsaturated fatty acids. A mechanism for
the coordinate suppression of lipogenic genes by polyunsaturated
fats. J Biol Chem. 274:23577–23583. 1999. View Article : Google Scholar
|
|
32
|
Pettinelli P and Videla LA: Up-regulation
of PPAR-gamma mRNA expression in the liver of obese patients: an
additional reinforcing lipogenic mechanism to SREBP-1c induction. J
Clin Endocrinol Metab. 96:1424–1430. 2011. View Article : Google Scholar
|
|
33
|
Mak PA, Laffitte BA, Desrumaux C, et al:
Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene
cluster in murine and human macrophages. A critical role for
nuclear liver X receptors alpha and beta. J Biol Chem.
277:31900–31908. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Berbée JF, van der Hoogt CC, Sundararaman
D, Havekes LM and Rensen PC: Severe hypertriglyceridemia in human
APOC1 transgenic mice is caused by apoC-I-induced inhibition of
LPL. J Lipid Res. 46:297–306. 2005.PubMed/NCBI
|
